Company intelligence / Profile preview

Fuji Pharma

Ownership: Private
Development stage: Other

Overview

Fuji Pharma is an established pharmaceutical company with over 50 years of focus on women's healthcare. The company manufactures and markets ethical pharmaceuticals across multiple therapeutic areas, including hormone drugs, biosimilars, and generic pharmaceuticals. It is the largest manufacturer in Japan in the women's healthcare field.

Therapeutic areas: HematologyImmunologyOtherWomen's HealthDermatologyOncology
Modalities: Small moleculeHormoneProteinBiosimilarAntibodyLiposomal encapsulation
Industry: Biotech

Partnerships

Terumo Corporation (capital alliance, 2009)Nobelpharma Co., Ltd. (marketing agreement for LUNABELL, 2007)Shionogi & Co., Ltd. (product acquisition, 2013)Ferring Pharmaceuticals Co., Ltd. (sales partnership for PROPESS, 2021)Alvotech Holdings (biosimilar commercialization partnership, 2018)Lotus Pharmaceutical Co., Ltd. (joint development of LENALIDOMIDE, 2024)

Beyond the preview

Go deeper on Fuji Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuji Pharma.